Frazier Life Sciences Management’s Arvinas ARVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-285,331
| Closed | -$5.47M | – | 49 |
|
|
2024
Q4 | $5.47M | Hold |
285,331
| – | – | 0.23% | 46 |
|
|
2024
Q3 | $7.03M | Hold |
285,331
| – | – | 0.28% | 46 |
|
|
2024
Q2 | $7.6M | Hold |
285,331
| – | – | 0.36% | 41 |
|
|
2024
Q1 | $11.8M | Hold |
285,331
| – | – | 0.5% | 40 |
|
|
2023
Q4 | $11.7M | Hold |
285,331
| – | – | 0.63% | 38 |
|
|
2023
Q3 | $5.6M | Hold |
285,331
| – | – | 0.37% | 42 |
|
|
2023
Q2 | $7.08M | Hold |
285,331
| – | – | 0.42% | 37 |
|
|
2023
Q1 | $7.8M | Hold |
285,331
| – | – | 0.56% | 34 |
|
|
2022
Q4 | $9.76M | Hold |
285,331
| – | – | 0.61% | 33 |
|
|
2022
Q3 | $12.7M | Hold |
285,331
| – | – | 0.98% | 25 |
|
|
2022
Q2 | $12M | Buy |
285,331
+15,000
| +6% | +$631K | 1.13% | 23 |
|
|
2022
Q1 | $18.2M | Buy |
+270,331
| New | +$18.2M | 1.55% | 20 |
|